• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Clin Biochem . ANNALS EXPRESS: Performance verification of COVID-19-specific antibody detection by using four chemiluminescence immunoassay syst

tetano

Editor, Senior Moderator
Ann Clin Biochem


. 2020 Sep 22;4563220963847.
doi: 10.1177/0004563220963847. Online ahead of print.
ANNALS EXPRESS: Performance verification of COVID-19-specific antibody detection by using four chemiluminescence immunoassay systems


Yafang Wan[SUP] 1 [/SUP], Zhijie Li[SUP] 1 [/SUP], Kun Wang[SUP] 1 [/SUP], Tian Li[SUP] 1 [/SUP], Pu Liao[SUP] 1 [/SUP]



Affiliations

Abstract

Objectives: The purpose of the current study was to evaluate the analytical performance of seven kits for detecting IgM/IgG antibodies against coronavirus (SARS-CoV-2) by using four chemiluminescence immunoassay systems.
Methods: Fifty patients diagnosed with SARS-CoV-2 infection and 130 controls without coronavirus infection from the General Hospital of Chongqing were enrolled in the current retrospective study. Four chemiluminescence immunoassay systems, including seven IgM/IgG antibody detection kits for SARS-CoV-2 (A_IgM, A_IgG, B_IgM, B_IgG, C_IgM, C_IgG, and D_Ab), were employed to detect antibody concentrations. The chi-square test, the receiver operating characteristic (ROC) curve and Youden?s index were determined to verify the cutoff value of each detection system.
Results: The repeatability verification results of the A, B, C, and D systems are all qualified. D-Ab performed best (92% sensitivity and 99.23% specificity), and B_IgM performed worse than the other systems. Except for the A_IgM and C_IgG systems, the optimal diagnostic thresholds and cutoff values of the other kits and their recommendations are inconsistent with each other. B_IgM had the worst AUC, and C_IgG had the best diagnostic accuracy. More importantly, the B_IgG system had the highest false positive rate for testing patients with AIDS, tumours and pregnancies. The A_IgM system test showed the highest false positive rates among elderly individuals over 90 years old. COVID-2019 IgM/IgG antibody test systems exhibit performance differences.
Conclusions: The D-Ab serum diagnosis kit is the most reliable detection system for anti-SARS-CoV-2 antibodies, which can be used as an alternative method for nucleic acid testing.

Keywords: Analytical systems; Statistics.
 
Back
Top Bottom